carbamates has been researched along with Colitis, Granulomatous in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Genomic DNA from 202 patients with Crohn's disease (CD) and 206 healthy controls was analyzed for the C385A polymorphism in the FAAH gene to address a possible role in humans." | 1.35 | Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. ( Brand, S; Buckley, NE; Emmerdinger, D; Göke, B; Keenan, CM; Lutz, B; Massa, F; Patel, KD; Sharkey, KA; Sibaev, A; Storr, MA; Yüce, B; Zhang, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Storr, MA | 1 |
| Keenan, CM | 1 |
| Emmerdinger, D | 1 |
| Zhang, H | 1 |
| Yüce, B | 1 |
| Sibaev, A | 1 |
| Massa, F | 1 |
| Buckley, NE | 1 |
| Lutz, B | 1 |
| Göke, B | 1 |
| Brand, S | 1 |
| Patel, KD | 1 |
| Sharkey, KA | 1 |
1 other study available for carbamates and Colitis, Granulomatous
| Article | Year |
|---|---|
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates | 2008 |